NurseTrust: Facilitating Nurse Leadership in Population Health
One of the main goals of NurseTrust is to identify and guide upcoming nurse leaders who can contribute to the advancement of population health and healthcare.
News
Assay to Detect Antibodies to SARS-CoV-2 in Human Serum or Plasma
The researchers found that samples from patients with COVID-19 showed strong reactivity to both the full-length S protein and the RBD.
Osimertinib-Associated Cardiac Toxicity: A Retrospective Study
The incidence of osimertinib-associated grade 3 or higher cardiac adverse events was 4.9% in a retrospective NSCLC population.
Long-Term AEs Persist in Some Survivors of Testicular Cancer
A subset of testicular cancer survivors experience persistent, treatment-related, long-term adverse health outcomes that affect their ability to work.
Polypharmacy Increases Risk of Post Chemotherapy Inpatient Hospitalization for Older Patients
Patients with cancer aged 65 and older are likely to be taking 5 or more medications before treatment with IV chemotherapy, which can complicate posttreatment care.
Low-Dose Aspirin Reduced Risk of HCC in Patients With HBV or HCV
In a registry study, patients with HBV or HCV who began low-dose aspirin had lower rates of HCC and 10-year liver-related mortality compared with nonusers.
Mitomycin C May Reduce Urothelial Recurrence Risk in UTUC
In a small study, single-dose instillation of mitomycin C immediately following therapeutic ureteroscopy for upper tract urothelial carcinoma was associated with an 87% decreased risk of urothelial recurrence.
Challenges, Facilitators of Spiritual Care for Family Members of Patients in the ICU
Herein, spiritual care was defined as “that which recognizes and responds to the needs of the human spirit, including the need for meaning, purpose, and connection.”
Newly Developed Rapid Point of Care Assay for Acute Promyelocytic Leukemia Diagnosis
Given the difficulty in definitevely diagnosing acute promyelocytic leukemia, researchers sought to develop a rapid point of care diagnostic assay.
Management of Patients With Myelofibrosis Experiencing Ruxolitinib Failure
Identification of the underlying pattern for ruxolitinib failure in patients with myelofibrosis is a significant factor in determining appropriate treatment.
Carboplatin Plus Pemetrexed Found Noninferior to Docetaxel in Older Patients With Nonsquamous NSCLC
A phase 3 trial of elderly patients with nonsquamous NSCLC demonstrated that carboplatin + pemetrexed prolonged survival with an improved safety profile compared with docetaxel.
Outpatient Induction Chemotherapy for Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
With adequate support from a multidisciplinary care team, outpatient induction chemotherapy was safe for these patients.
Time to Radiotherapy After Glioblastoma Resection Affects Survival Outcomes
A large retrospective analysis demonstrated that a delay of 4 to 8 weeks for adjuvant radiotherapy following surgical resection of glioblastoma improved survival.
Persistent Leukocytosis as a Marker for Disease Progression in Polycythemia Vera
Although most notably associated with erythrocytosis, hematologic manifestations of polycythemia vera may also include leukocytosis and thrombocytosis.
Hairy Cell Leukemia: Cladribine With Concurrent Rituximab May Improve Outcomes
Rituximab has some single-agent activity in HCL, but there is evidence that it may eliminate MRD when used with cladribine or pentostatin.
FDA Approves Imfinzi for Extensive-Stage Small Cell Lung Cancer
The approval was based on data from the CASPIAN study, an active-controlled, open-label trial that investigated the combination of durvalumab plus chemotherapy vs chemotherapy alone.
Hazardous Drug Exposure Among Oncology Nurses During Spills
In an effort to gather data on hazardous drug exposure, researchers surveyed oncology nurses regarding spills and use of personal protective equipment at 12 participating academic infusion centers.
PPE Use During COVID-19: A Double Challenge
The COVID-19 pandemic is challenging nurses and hospitals to find unique solutions to maintain patient care in an unprecedented situation.
Induction in Transplant-Eligible Mantle Cell Lymphoma With Rituximab and Cytarabine Added to Rituximab and Bendamustine
The researchers found that high rates of remission could be achieved with induction therapy using rituximab/bendamustine in addition to rituximab/cytarabine.
Brentuximab Vedotin With Bendamustine for Patients With Refractory or Multiple Relapsed Classic Hodgkin Lymphoma
A retrospective analysis found encouraging evidence for the use of BvB in treatment of RR-cHL.
Want to read more?
Please login or register first to view this content.
Next post in Web Exclusives
